Pike J W
J Biol Chem. 1982 Jun 25;257(12):6766-75.
The molecular action of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is thought to involve its localization within the nucleus of target cells, a process mediated by intracellular receptors. This report probes both the association between chick intestinal 1,25(OH)2D3 receptors and purified homologous nuclei and the interaction between this receptor and nucleic acids. 1,25(OH)2D3 receptors bound to purified nuclei in a apparently saturable manner (Kd = 2.2-4.8 X 10(-10) M) under conditions of intermediate ionic strength and constant protein concentration. Nuclear binding was hormone-dependent; whereas receptor-hormone complex (Rs) binds to nuclei under the ionic conditions employed here (greater than 70%), hormone-free (R0) receptors do not bind (less than 10%). Binding was localized to the nuclear chromatin fraction and was extremely sensitive to KCl concentration both in the incubation medium and during postincubation treatment of nuclei. The interaction appeared to be temperature-independent, suggesting the lack of a classic activation event characteristic of most steroid receptors. Partial digestion of intestinal nuclei with DNase I eliminated subsequent receptor binding by greater than 95%, pointing to the involvement of DNA in the binding interaction. In turn, receptors were found to bind to both DNA and RNA, a characteristic independent of receptor aggregation, but sensitive to disruption with increasing ionic strength buffers. Elution of both Rs and R0 from DNA appeared identical (0.28 M KCl), whereas the strength of interaction with RNA was much less (0.12 M KCl). Thus, while there appeared to be a fundamental difference between R0 and Rs, such that only the binding of receptor-hormone complex to nuclei was allowed under the conditions employed here, this characteristic was not observed during DNA binding. Nevertheless, the possibility exists that the in vivo interaction between 1,25(OH)2D3 receptor and nuclei involves DNA and that this nuclear constituent may be the ultimate site of action of this unique sterol hormone.
1,25 - 二羟基维生素D3(1,25(OH)2D3)的分子作用被认为涉及其在靶细胞核内的定位,这一过程由细胞内受体介导。本报告探究了鸡肠道1,25(OH)2D3受体与纯化的同源细胞核之间的关联以及该受体与核酸之间的相互作用。在中等离子强度和恒定蛋白质浓度条件下,1,25(OH)2D3受体以明显可饱和的方式(Kd = 2.2 - 4.8×10(-10) M)与纯化的细胞核结合。核结合是激素依赖性的;在此处采用的离子条件下(大于70%),受体 - 激素复合物(Rs)与细胞核结合,而无激素(R0)受体不结合(小于10%)。结合定位于核染色质部分,并且在孵育介质以及细胞核孵育后处理过程中对KCl浓度极为敏感。这种相互作用似乎与温度无关,表明缺乏大多数类固醇受体典型的经典激活事件。用DNase I对肠道细胞核进行部分消化后,随后的受体结合减少了95%以上,表明DNA参与了结合相互作用。反过来,发现受体与DNA和RNA都能结合,这一特性与受体聚集无关,但对增加离子强度缓冲液的破坏敏感。Rs和R0从DNA上的洗脱情况相同(0.28 M KCl),而与RNA相互作用的强度则小得多(0.12 M KCl)。因此,虽然R0和Rs之间似乎存在根本差异,即在此处采用的条件下只有受体 - 激素复合物与细胞核的结合是允许的,但在DNA结合过程中未观察到这一特性。然而,1,25(OH)2D3受体与细胞核在体内的相互作用涉及DNA的可能性存在,并且这种核成分可能是这种独特固醇激素的最终作用位点。